Related Experiment Video
Updated: Jun 10, 2025

08:45
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.2K
PP2A negatively regulates NK cell T-bet expression and anti-tumor effector function
Yui Shinzawa1, Daisuke Hara1, Yuki Shinguryo1
1Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
International Immunology
|October 15, 2024
Summary
Protein phosphatase 2A (PP2A) negatively regulates T-bet expression in natural killer (NK) cells. Inhibiting PP2A enhances NK cell anti-tumor immunity via mTOR signaling, improving cancer treatment outcomes.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- T-bet is crucial for natural killer (NK) cell anti-tumor immunity.
- The regulation of T-bet expression in NK cells is not fully understood.
Purpose of the Study:
- To identify NK cell-intrinsic regulators of T-bet expression.
- To elucidate the mechanism by which these regulators affect NK cell function.
Main Methods:
- T-bet-luciferase reporter assay screening.
- Treatment with protein phosphatase 2A (PP2A) inhibitors (PP2Ai) or PP2A siRNA.
- Analysis of T-bet, granzyme B, and IFN-γ expression in NK cells.
- Western blot analysis of mTOR and S6 phosphorylation.
- Assessment of NK cell cytotoxicity and in vivo anti-tumor activity.
Main Results:
- PP2A inhibition (PP2Ai or siRNA) upregulated T-bet expression in NK cells.
- PP2Ai treatment increased T-bet, granzyme B, and IFN-γ in NK cells from mice.
- PP2Ai enhanced NK cell cytotoxicity and IFN-γ production.
- PP2Ai treatment inhibited lung metastasis in a B16 melanoma model.
- The observed effects were dependent on NK cells and mTOR signaling.
Conclusions:
- PP2A acts as a negative regulator of T-bet expression and NK cell effector function.
- PP2A inhibition enhances anti-tumor immunity through an mTOR-dependent pathway.
- Targeting PP2A may represent a novel strategy for cancer immunotherapy.
More Related Videos
Related Concept Videos
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
T Cell Activation and Clonal Selection
679
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
679

